Back to Search
Start Over
Reply to Kow and Hasan.
- Source :
- Clinical Infectious Diseases; 11/1/2021, Vol. 73 Issue 9, pe2849-e2850, 2p
- Publication Year :
- 2021
-
Abstract
- The article explores clinical observations about our randomized METCOVID clinical trial on the efficacy of methylprednisolone (MP) in the adjuvant treatment of coronavirus disease 2019 (COVID-19). As the benefit of MP for 5 days was estimated to be 50%, it is likely that the overall final analysis was not powered to estimate such a difference.
- Subjects :
- METHYLPREDNISOLONE
DRUG efficacy
COVID-19
HYPERGLYCEMIA
STEROIDS
Subjects
Details
- Language :
- English
- ISSN :
- 10584838
- Volume :
- 73
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- Clinical Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 153439893
- Full Text :
- https://doi.org/10.1093/cid/ciaa1426